Jiu-wu Bai

Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Just Because it Could be Done: Rethinking Cryobiopsy in Pulmonary Alveolar Proteinosis.

Just Because it Could be Done: Rethinking Cryobiopsy in Pulmonary Alveolar Proteinosis.

Journal: Journal of bronchology & interventional pulmonology

Published: September 21, 2025

The Application of Transbronchial Cryo-biopsy in the Diagnosis of Pulmonary Alveolar Proteinosis.

The Application of Transbronchial Cryo-biopsy in the Diagnosis of Pulmonary Alveolar Proteinosis.

Journal: Journal of bronchology & interventional pulmonology

Published: October 19, 2024

The role of volatile organic compounds for assessing characteristics and severity of non-cystic fibrosis bronchiectasis: an observational study.

The role of volatile organic compounds for assessing characteristics and severity of non-cystic fibrosis bronchiectasis: an observational study.

Journal: Frontiers in medicine

Published: November 27, 2023

Quality-of-Life Bronchiectasis Respiratory Symptom Scale Predicts the Risk of Exacerbations in Adults with Bronchiectasis: A Prospective Observational Study.

Quality-of-Life Bronchiectasis Respiratory Symptom Scale Predicts the Risk of Exacerbations in Adults with Bronchiectasis: A Prospective Observational Study.

Journal: Annals of the American Thoracic Society

Published: November 14, 2023

Severe Pulmonary Hypertension Increased All-cause Mortality in Patients With Bronchiectasis.

Severe Pulmonary Hypertension Increased All-cause Mortality in Patients With Bronchiectasis.

Journal: Archivos de bronconeumologia

Published: July 18, 2023

Vitamin B6 regulates IL-33 homeostasis to alleviate type 2 inflammation.

Vitamin B6 regulates IL-33 homeostasis to alleviate type 2 inflammation.

Journal: Cellular & molecular immunology

Published: December 09, 2022

Updated severity and prognosis score of pulmonary alveolar proteinosis: A multi-center cohort study in China.

Updated severity and prognosis score of pulmonary alveolar proteinosis: A multi-center cohort study in China.

Journal: Frontiers in medicine

Published: September 30, 2022

Altered fecal microbiome and metabolome in adult patients with non-cystic fibrosis bronchiectasis.

Altered fecal microbiome and metabolome in adult patients with non-cystic fibrosis bronchiectasis.

Journal: Respiratory research

Published: August 11, 2022

The impact of depression and anxiety on the risk of exacerbation in adults with bronchiectasis: a prospective cohort study.

The impact of depression and anxiety on the risk of exacerbation in adults with bronchiectasis: a prospective cohort study.

Journal: The European respiratory journal

Published: July 14, 2022

CYFRA21-1 is a more sensitive biomarker to assess the severity of pulmonary alveolar proteinosis.

CYFRA21-1 is a more sensitive biomarker to assess the severity of pulmonary alveolar proteinosis.

Journal: BMC pulmonary medicine

Published: July 31, 2021

Bronchoscopic airway clearance therapy for acute exacerbations of bronchiectasis.

Bronchoscopic airway clearance therapy for acute exacerbations of bronchiectasis.

Journal: EBioMedicine

Published: December 27, 2020

The clinical characteristics and prognosis of ABPA are closely related to the mucus plugs in central bronchiectasis.

The clinical characteristics and prognosis of ABPA are closely related to the mucus plugs in central bronchiectasis.

Journal: The clinical respiratory journal

Published: May 31, 2019

Showing 1-12 of 17

Last Updated: 09/26/2026